✦ LIBER ✦

The preclinical pharmacology of âArimidexâ (Anastrozole; ZD1033) â a potent, selective aromatase inhibitor

✍ Scribed by Dukes, Michael; Edwards, Philip N.; Large, Michael; Smith, Ian K.; Boyle, Thomas

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of a potent and selecti

✍ H. Koyama 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 147 KB

104. Randomized phase III study of the n

✍ A.U. Buzdar; P.V. Plourde; S.E. Jones; C.L. Voge; J.M. Wolters; P.D. Eisenberg 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 188 KB

Preclinical pharmacology of lumiracoxib:

✍ Ronald Esser; Carol Berry; Zhengming Du; Janet Dawson; Alyson Fox; Roger A Fujim 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 246 KB

Preclinical pharmacology of robenacoxib:

✍ J. N. KING; J. DAWSON; R. E. ESSER; R. FUJIMOTO; E. F. KIMBLE; W. MANIARA; P. J. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 342 KB

1. Arimidex: profile of a potent, select

✍ M. Dukes; P.N. Edwards; P.M. Large; I.K. Smith 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 290 KB

Preclinical pharmacology of TP1, a novel

✍ J.-W. Tian; W.-L. Jiang; Y. Zhong; Q. Meng; Y. Gai; H.-B. Zhu; J. Hou; Y. Xing; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 813 KB

The preclinical pharmacology of âArimidexâ (Anastrozole; ZD1033) â a potent, selective aromatase inhibitor